PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50119C00022Advanced research and development of rvsv-marv — Public Health Vaccines LLC

Public Health Vaccines LLC holds $32.8M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Jan 31, 2029 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Public Health Vaccines LLC

Recipient

Jan 31, 2029

PoP end

$66.7M

Obligated

541714

NAICS

AN13

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Public Health Vaccines LLC — $90

Contract facts

NONE

Contract number75A50119C00022

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

IncumbentPublic Health Vaccines LLC

UEISX5LJU3KWF93

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN13

Place of performanceCAMBRIDGE, MA

PoP end (current)Jan 31, 2029

Obligated$66.7M

ADVANCED RESEARCH AND DEVELOPMENT OF RVSV-MARV VACCINE. is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Public Health Vaccines LLC. Estimated value $89M ($66.7M obligated). Current period of performance ends Jan 31, 2029. Last award drew 1 bidder. Place of performance: CAMBRIDGE, MA.

ADVANCED RESEARCH AND DEVELOPMENT OF RVSV-MARV VACCINE.

Recompete timing

Public

● Expiring in 878 days

Current PoP ends Jan 31, 2029 (878 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Jul 31, 2027.

Incumbent footprint

Public record

Public Health Vaccines LLC — $32.8M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$32.8M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50119C00022?

75A50119C00022 (Advanced research and development of rvsv-marv) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $89M, currently held by Public Health Vaccines LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50119C00022?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50119C00022 to Public Health Vaccines LLC.

Who is the incumbent on 75A50119C00022?

Public Health Vaccines LLC is the incumbent with $32.8M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Jan 31, 2029.

When does Public Health Vaccines LLC’s 75A50119C00022 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 31, 2029. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75A50119C00022 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action Jun 8, 2026